Surgical and Patient Reported Outcomes in Robotic Mastectomy

Inclusion Criteria

• •Women aged 21-70, with invasive breast cancer, ductal carcinoma in situ (DCIS), Breast Cancer (BRCA) gene or other breast cancer genetic mutation carriers or high risk female patients who are otherwise candidates for conventional NSM/SSM will be eligible for the study. All suitable patients will be offered the option of R-NSM/ R-SSM.
• •For patients with breast cancer (invasive or DCIS), selection criteria include but not limited to:
• •1. Early breast cancer
• •2. Tumor size less than 5 cm
• •3. No evidence of lymph node metastases
• •4. No evidence of skin or chest wall invasion.